Barry P. Flannelly - 12 Jun 2025 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role: Director
Signature: /s/ Mary Grendell, Attorney-in-fact
Issuer symbol: TARA
Transactions as of: 12 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 13 Jun 2025, 16:05:10 UTC
Previous filing: 03 Apr 2025
Next filing: 07 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Flannelly Barry P	Director	C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK	/s/ Mary Grendell, Attorney-in-fact	13 Jun 2025	0001615842

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TARA	Stock Option (Right to Buy)	Award	$0	+24K		$0.00	24K	12 Jun 2025	Common Stock	24K	$3.26	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.